CBD Stock Overview
Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cannabis Poland S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.30 |
| 52 Week High | zł1.04 |
| 52 Week Low | zł0.29 |
| Beta | 0.83 |
| 1 Month Change | -32.89% |
| 3 Month Change | -41.33% |
| 1 Year Change | -10.68% |
| 3 Year Change | -80.28% |
| 5 Year Change | -55.74% |
| Change since IPO | -72.64% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBD | PL Pharmaceuticals | PL Market | |
|---|---|---|---|
| 7D | -14.5% | -1.8% | -0.6% |
| 1Y | -10.7% | 28.6% | -5.3% |
Return vs Industry: CBD underperformed the Polish Pharmaceuticals industry which returned 26.3% over the past year.
Return vs Market: CBD underperformed the Polish Market which returned -4.9% over the past year.
Price Volatility
| CBD volatility | |
|---|---|
| CBD Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in PL Market | 8.7% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: CBD's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: CBD's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1 | n/a | www.cp-sa.pl |
Cannabis Poland S.A. engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland. The company sells CBD oils and herbs, inhalers, and vaporizers, as well as cosmetics. It sells its products through HempWish.pl and Vapem.eu online stores.
Cannabis Poland S.A. Fundamentals Summary
| CBD fundamental statistics | |
|---|---|
| Market cap | zł14.81m |
| Earnings (TTM) | -zł1.62m |
| Revenue (TTM) | zł236.52k |
62.6x
P/S Ratio-9.1x
P/E RatioIs CBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBD income statement (TTM) | |
|---|---|
| Revenue | zł236.52k |
| Cost of Revenue | zł269.15k |
| Gross Profit | -zł32.63k |
| Other Expenses | zł1.59m |
| Earnings | -zł1.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.033 |
| Gross Margin | -13.80% |
| Net Profit Margin | -686.63% |
| Debt/Equity Ratio | 0.7% |
How did CBD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 06:52 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cannabis Poland S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|